Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy - Krol, Augustinus D.G; Berenschot, Henriëtte W.A; Doekharan, Dew; Henzen-Logmans, Sonja; van der Holt, Bronno; van ‘t Veer, Mars B (Radiotherapy and oncology, 2001)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Combined Modality Therapy; Combined modality treatment; Cyclophosphamide - administration & dosage; Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy; Disease-Free Survival; Doxorubicin - administration & dosage; Female; Humans; Intermediate and high grade; Lymphoma, Non-Hodgkin - drug therapy; Lymphoma, Non-Hodgkin - mortality; Lymphoma, Non-Hodgkin - radiotherapy; Male; Middle Aged; Non-Hodgkin's lymphoma; Prednisone - administration & dosage; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Stage I/IE; Survival Rate; Vincristine - administration & dosage; Stage I/IE; Combined modality treatment; Non-Hodgkin's lymphoma; Radiotherapy; Intermediate and high grade; Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy